Story · Medicine & Biotech

FDA Approves a Second Weekly Basal Insulin Option for Type 2 Diabetes

1 outlet · first reported by JAMA Internal Medicine 3d ago

Coverage, in order

  1. 3d ago
    JAMA Internal Medicine indie study
    FDA Approves a Second Weekly Basal Insulin Option for Type 2 Diabetes

    The US Food and Drug Administration (FDA) approved another once-weekly basal insulin injection for adults with type 2 diabetes.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.